| 000 | 01819 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250516015534.0 | ||
| 264 | 0 | _c20101230 | |
| 008 | 201012s 0 0 eng d | ||
| 022 | _a1533-4406 | ||
| 024 | 7 |
_a10.1056/NEJMoa1006885 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLassen, Michael Rud | |
| 245 | 0 | 0 |
_aApixaban versus enoxaparin for thromboprophylaxis after hip replacement. _h[electronic resource] |
| 260 |
_bThe New England journal of medicine _cDec 2010 |
||
| 300 |
_a2487-98 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAnticoagulants _xadverse effects |
| 650 | 0 | 4 | _aArthroplasty, Replacement, Hip |
| 650 | 0 | 4 | _aConfidence Intervals |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 |
_aEnoxaparin _xadverse effects |
| 650 | 0 | 4 | _aFactor Xa Inhibitors |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHemorrhage _xchemically induced |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInjections, Subcutaneous |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPostoperative Complications _xprevention & control |
| 650 | 0 | 4 |
_aPyrazoles _xadverse effects |
| 650 | 0 | 4 |
_aPyridones _xadverse effects |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aVenous Thromboembolism _xprevention & control |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aGallus, Alexander | |
| 700 | 1 | _aRaskob, Gary E | |
| 700 | 1 | _aPineo, Graham | |
| 700 | 1 | _aChen, Dalei | |
| 700 | 1 | _aRamirez, Luz Margarita | |
| 773 | 0 |
_tThe New England journal of medicine _gvol. 363 _gno. 26 _gp. 2487-98 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1056/NEJMoa1006885 _zAvailable from publisher's website |
| 999 |
_c20463454 _d20463454 |
||